天美传媒

Arti Thangudu, MD, is a triple board-certified physician and endocrinology, diabetes, and thyroid specialist who provides high-level, well-rounded care at Complete Medicine in San Antonio, Texas. She takes an evidence-based approach to care, focusing on the whole patient, not their disease or symptoms. At her membership-based practice, Dr. Thangudu offers her patients direct access, frequent coaching, and continuous blood glucose monitoring. After earning her Bachelor of Science in Journalism at Northwestern University in Evanston, Illinois, Dr. Thangudu received her Doctor of Medicine from the University of Texas Health Science Center in San Antonio. She completed a rigorous internship in internal medicine at Baylor College of Medicine, where she treated thousands of the sickest patients in public, private, and Veteran’s Administration hospitals and clinics throughout Houston, Texas. She then relocated to New Orleans, Louisiana, to complete her internal medicine residency at Tulane University. Dr. Thangudu moved to Pittsburgh, Pennsylvania, to complete her fellowship in endocrinology, diabetes, and metabolism at the University of Pittsburgh Medical Center, one of the busiest endocrinology training centers in the country. During her fellowship, she saw thousands of complex and rare cases in and out of the hospital and participated in research and quality improvement projects to improve care for people with diabetes. After her training, she moved on to work at one of the largest endocrinology groups in the country, where her passion grew and pushed her to pursue nutritional training at Cornell University’s Center for Nutrition Studies. Dr. Thangudu holds board certification in internal and lifestyle medicine, as well as endocrinology, diabetes, and metabolism. She’s also certified in plant-based nutrition.

Bio:
Born Hanover, NH, B.A. Chemistry Duke University 1972, PhD Physiology, University of Minnesota 1981, postdoc Pulmonary Medicine, UCLA 1980-1986, faculty USD School of Medicine 1986-present

Teaching Interests:
physiology (both basic and advanced), introductory biology for future elementary teachers, biomedical ethics, teaching fundamentals for graduate students, membrane transport, nerve and muscle physiology, XDIS, FYE

Research Interests:
how to improve student learning using innovative and active pedagogy, review articles of scientific concepts for the lay public

Education:
Ph D, physiology, University of Minnesota, 1981
BA, chemistry, Duke University, 1972
Grants:
SD BRIN Bridge Funding, National Institutes of Health. (2014 - 2015)
SPURA - Summer Program for Undergraduate Research in Addiction, NIH/NIDA. Grant Role: Co-Principal. (2013 - 2018)
SPURA - Summer Program for Undergraduate Research in Addiction, NIH/NIDA. Grant Role: Co-Principal. (2013 - 2018)
RCN-UBE Incubator: Growing a Physiology Education Community of Practice, National Science Foundation. Grant Role: Co-Principal. (2013 - 2014)
South Dakota Science and Mathematics Teacher Enhancement: Integrating Math and Science and Using Topical Issues in Science Instruction, SD Board of Regents and US Dept of Education. Grant Role: Co-Principal. (2011 - 2012)
Science and Mathematics Instruction In Context for South Dakota in the 21st Century, SD Board of Regents and US Dept of Education. Grant Role: Co-Principal. (2010 - 2011)
Supplement to SD BRIN for undergraduate and high school researchers, NIH. (2009 - 2010)
SD Biomedical Research Infrastructure Network Supplemental, NIH. Grant Role: Principal. (2001 - 2014)
IDeA Networks of Biomedical Research Excellence, NIH. Grant Role: Principal.
RCN-UBE Incubator: Growing a Physiology Education Community of Practice, National Science Foundation.

Audrey A. Vasauskas, PhD, serves as Director of Research & Grant Development and Associate Professor of Physiology. Dr. Vasauskas obtained her Bachelor of Science in biology from Mount Saint Mary鈥檚 University in Maryland. She earned her PhD and completed post-doctoral training from the University of South Alabama College of Medicine. Dr. Vasauskas has been the recipient of several extramural research grants from the National Institutes of Health and the American Heart Association. She has also served as a science policy and research advocate to the United States Congress. Dr. Vasauskas has been teaching cell and system physiology for over a decade and has mentored many undergraduate, graduate and medical students both in academia and industry. Prior to her career in academia, she spent several years in the biotechnology industry as project leader for oncology diagnostic development. During her time at ACOM, she has served as Research Committee chair and principal investigator. Dr. Vasauskas鈥檚 current research includes the molecular changes that occur within endothelial cells in the pathology known as pulmonary arterial hypertension. Specifically, her NIH-funded research investigates potential players in endothelial to mesenchymal transition, or the process by which endothelial cells transition to a smooth muscle, constrictive phenotype.

Parker's research focuses on developing an understanding of how sex hormones like estrogen and testosterone regulate the production of sexual signals used in mate choice. He uses snakes as a model group of vertebrates because snakes rely almost exclusively on chemical cues (pheromones) to identify and choose between mates.
Parker's research has been used in collaboration with the U.S. Department of Agriculture, the U.S. Geological Survey and the Florida Institute of Technology to improve the management of invasive species, mainly Burmese pythons in the Florida Everglades. His research is also being used to examine similar questions about Argentine tegu lizards.
He has a bachelor's degree from the University of Arkansas, Fayetteville; a master's degree from Washington State University and a doctorate from Oregon State University.

Dr. Mehmood Khan’s distinguished career has included several senior corporate roles, including Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, and President of Global R&D at Takeda Pharmaceuticals.
Before moving into the private sector Dr. Khan was a faculty member in endocrinology at the Mayo Clinic and Medical School, where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also led programs in diabetes, endocrinology, metabolism, and nutrition in Minneapolis.
Dr. Khan is a member of the Board of Directors of Reckitt Benckiser and of the Saudi Research, Development, and Innovation Authority (RDIA), Executive Chairman of Life Biosciences, a member of the Saudi National Biotechnology Strategy Steering Committee, and Chairman of the Visiting Committee on Advanced Technology of the United States’ National Institute of Standards and Technology (NIST).
Dr. Khan earned his medical degree from the University of Liverpool School of Medicine, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a Fellow of the Royal College of Physicians in London, a Fellow of the American College of Endocrinology, and an Elected Fellow in the Department of Pharmacology at University of Oxford.